Liquid Laxative (Sodium Picosulfate)

After oral administration, sodium picosulfate reaches the colon where gut bacteria convert it into an active metabolite. This metabolite activates enteric nerves, increasing peristaltic activity and decreasing water reabsorption, which together promote the rapid passage of stool.

The appropriate dose is determined by the prescribing healthcare professional based on the indication, patient age, weight, and clinical condition. Dosage instructions are provided on the prescription label and should be followed exactly as directed.

Safety data for sodium picosulfate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with polyethylene glycol (PEG) based preparations, sodium picosulfate offers a stimulant mechanism that may produce a quicker onset of action. PEG solutions are generally isotonic and cause less cramping, while sodium picosulfate can be more effective for rapid bowel cleansing but may have a higher incidence of abdominal discomfort.

Store the oral liquid at ambient temperature, preferably below 25 °C, in its original container. Protect it from moisture, direct sunlight, and extreme temperature fluctuations. Keep the bottle tightly closed when not in use to maintain product stability.

The product is taken orally, usually as a measured dose of the liquid. It should be swallowed directly or mixed with a small amount of water as instructed by the prescriber. Patients are advised to follow any fluid intake recommendations to reduce the risk of dehydration.

Serious risks include severe dehydration, electrolyte disturbances such as hyponatremia, rectal bleeding, allergic reactions, and, in extremely rare cases, colonic perforation. Patients should seek immediate medical attention if they experience persistent vomiting, severe abdominal pain, or signs of an allergic response.

Individuals with a known hypersensitivity to sodium picosulfate, those with complete intestinal obstruction, severe renal impairment, or active inflammatory bowel disease should avoid this product. It is also contraindicated in patients for whom rapid fluid loss could be hazardous, unless specifically directed by a clinician.